TD Cowen reiterates Buy on BridgeBio Pharma stock, cites cardiac data
Covered in this story
What has happened since
- Bridgebio Pharma Inc is up 3.0% since this was published, 17 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
TD Cowen’s $110 target on $BBIO is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
TD Cowen’s track record →Analyst targets on Bridgebio Pharma Inc
- Jefferies: $66.1 → $110 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $BBIO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Bridgebio Pharma Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.